ERBB2 and small cell lung carcinoma: We found that SCLC cells were rather unresponsive to antigen-specific T cell killing, however, pre-treatment with an ERBB2 inhibitor restored effective T cell killing of SCLC by induction of MHC-I (Fig. 6j–m).